Alcoholic liver disease

Seminars in Diagnostic Pathology

Volumn 23, Issue 3-4, 2006, Pages 149-160

  Yip, William W ^a   Burt, Alastair D ^b  

^a ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Abstinence; Cirrhosis; NAFLD; NASH; Steatohepatitis; Steatosis

Indexed keywords

ALCOHOL ABSTINENCE; ALCOHOL LIVER DISEASE; APOPTOSIS; ARTICLE; CELL DEATH; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; IRON OVERLOAD; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER NODULE; MORPHOLOGY; NONALCOHOLIC FATTY LIVER; PHENOTYPE; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SYSTEMATIC REVIEW; VIRUS HEPATITIS;

COMORBIDITY; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; HUMANS; LIVER DISEASES, ALCOHOLIC;

EID: 33846616400     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2006.11.002     Document Type: Article

References (93)

1. Keller M. A historical overview of alcohol and alcoholism. Cancer Res 39 (1979) 2822-2829
2. Mandayam S., Jamal M.M., and Morgan T.R. Epidemiology of alcoholic liver disease. Semin Liver Dis 24 (2004) 217-232
3. Bassendine M.F., and Day C.P. The inheritance of alcoholic liver disease. Baillières Clin Gastroenterol 12 (1998) 317-335
4. Lefkowitch J.H. Morphology of alcoholic liver disease. Clin Liver Dis 9 (2005) 37-53
5. Ishak K.G., Zimmerman H.J., and Ray M.B. Alcoholic liver disease: pathologic, pathogenetic and clinical aspects. Alcohol Clin Exp Res 15 (1991) 45-66
6. MacSween R.N., and Burt A.D. Histologic spectrum of alcoholic liver disease. Semin Liver Dis 6 (1986) 221-232
7. Baptista A., Bianchi L., De Groote J., et al. Alcoholic liver disease: morphological manifestations. Lancet 1 (1981) 707-711
8. Diehl A.M., Goodman Z., and Ishak K.G. Alcohol like liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95 (1988) 1056-1062
9. Brunt E.M. Non-alcoholic fatty liver disease. In: Burt A.D., Portmann B.C., and Ferrell L.D. (Eds). MacSween's Pathology of the Liver. (ed 5) (2006), Churchill Livingstone, Edinburgh 367-398
10. Burt A.D., Mutton A., and Day C.P. Diagnosis and interpretation of steatosis and steatohepatitis. Semin Diagn Pathol 15 (1998) 246-258
11. Williams R. Global challenges in liver disease. Hepatology 44 (2006) 521-526
12. Dam-Larsen S., Franzmann M.B., Christofferson P., et al. Histological characteristics and prognosis in patients with fatty liver. Scand J Gastroenterol 40 (2005) 460-467
13. Lieber C.S. Metabolism of alcohol. Clin Liver Dis 9 (2005) 1-35
14. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
15. Uchida T., Kao H., Quispe-Sjogren M., et al. Alcoholic foamy degeneration-a pattern of acute alcoholic injury of the liver. Gastroenterology 84 (1983) 683-692
16. Fromenty B., and Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanols, hormones and cytokines. J Hepatol 26 suppl (1997) 43-53
17. Teli M.R., Day C.P., Burt A.D., et al. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346 (1995) 987-990
18. Christoffersen P., Braendstrup O., Juhl E., et al. Lipogranulomas in human liver biopsies with fatty change. A morphological, biochemical and clinical investigation. Acta Pathol Microbiol Scand [A] 79 (1971) 150-158
19. Randall B. Sudden death and hepatic fatty metamorphosis: a North Carolina survey. JAMA 293 (1980) 1723-1725
20. Adachi M., and Brenner D.A. Clinical syndromes of alcoholic liver disease. Dig Dis 23 (2005) 255-263
21. Jensen K., and Gluud C. The Mallory body: theories on development and pathological significance (part 2 of a literature survey). Hepatology 20 (1994) 1330-1342
22. Pei R.J., Danbara N., Tsujita-Kyutoki M., et al. Immunohistochemical profiles of Mallory body by a panel of anti-cytokeratin antibodies. Med Electron Microsc 37 (2004) 114-118
23. Vyberg M., and Leth P. Ubiquitin: an immunohistochemical marker of Mallory bodies and alcoholic liver disease. APMIS Suppl 99 (1991) 46-52
24. Zatloukal K., Stumptner C., Fuchsbichler A., et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am J Pathol 160 (2002) 255-263
25. McClain C.J., Song Z., Barve S.S., et al. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 287 (2004) G497-G502
26. Thiele G.M.F.T.L., and Klaasen L.W. Immunologic mechanisms of alcoholic liver injury. Semin Liver Dis 24 (2004) 273-287
27. Farrell G.C. Drugs and steatohepatitis. Semin Liver Dis 22 (2002) 185-194
28. Bruguera M., Bertran A., Bombi J.A., et al. Giant mitochondria in hepatocytes: a diagnostic hint for alcoholic liver disease. Gastroenterology 73 (1977) 1383-1387
29. Feldstein A.E., and Gores G.J. Apoptosis in alcoholic and non-alcoholic steatohepatitis. Front Biosci 10 (2005) 3093-3099
30. Ribeiro P.S., Cortez-Pinto H., Sola S., et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of non-alcoholic and alcoholic steaetohepatitis patients. Am J Gastroenterol 99 (2004) 1708-1717
31. Mundt B., Wirth T., Zender L., et al. Tumour necrosis factor related apoptosis inducing ligand (TRAIL) induces hepatic steatosis in viral hepatitis and after alcohol intake. Gut 54 (2005) 1590-1596
32. Van Waes L., and Lieber C.S. Early perivenular sclerosis in alcoholic fatty liver: an index of progressive liver injury. Gastroenterology 73 (1977) 646-650
33. Savolainen V., Perola M., Lalu K., et al. Early perivenular fibrogenesis: precirrhotic lesions among moderate alcohol consumers and chronic alcoholics. J Hepatol 23 (1995) 524-531
34. Siegmund S.V., Dooley S., and Brenner D.A. Molecular mechanisms of alcohol-induced hepatic fibrosis. Dig Dis 23 (2005) 264-274
35. Edmondson H.A., Peters R.L., Reynolds T.B., et al. Sclerosing hyaline necrosis of the liver in the chronic alcoholic. A recognizable clinical syndrome. Ann Intern Med 59 (1963) 646-673
36. Diehl A.M. Recent events in alcoholic liver disease. V. Effects of ethanol on liver regeneration. Am J Physiol Gastrointest Liver Physiol 288 (2005) G1-G6
37. Berresford P.A., Sunter J.P., Harrison V., et al. Histological demonstration and frequency of intrahepatocytic copper in patients suffering from alcoholic liver disease. Histopathology 4 (1980) 637-643
38. Pariente E.A., Degott C., Martin J.P., et al. Hepatocytic PAS-positive diastase-resistant inclusions in the absence of alpha-1-antitrypsin deficiency: high prevalence in alcoholic cirrhosis. Am J Clin Pathol 76 (1981) 299-302
39. Graziadei I.W., Joseph J.J., Wiesner R.H., et al. Increased risk of chronic liver failure in adults with heterozygous alpha1-antitrypsin deficiency. Hepatology 28 (1998) 1058-1063
40. Lee F.I. Cirrhosis and hepatoma in alcoholics. Gut 7 (1966) 77-85
41. Voigt M.D. Alcohol in hepatocellular cancer. Clin Liver Dis 9 (2005) 151-169
42. Marrero J.A., Fontana R.J., Fu S., et al. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42 (2005) 218-224
43. Libbrecht L.D.V., and Roskams T. Preneoplastic lesions in human hepatocarcinogenesis. Liver Int 25 (2005) 16-27
44. Nakashima O., Kurogi M., Yamaguchi R., et al. Unique hypervascular nodules in alcoholic liver cirrhosis; identical to focal nodular hyperplasia-like lesions. J Hepatol 41 (2004) 992-998
45. Shaahib Y.H., El-Serag H.B., Davila J.A., et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 128 (2005) 620-626
46. Popper H., and Lieber C.S. Histogenesis of alcoholic fibrosis and cirrhosis in the baboon. Am J Pathol 98 (1980) 695-716
47. Nakano M., Worner T.M., and Lieber C.S. Perivenular fibrosis as precursor lesion of cirrhosis. JAMA 254 (1985) 627-630
48. Burt A.D., and MacSween R.N.M. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 39 (1986) 63-67
49. Goodman Z.D., and Ishak K.G. Occlusive venous lesions in alcoholic liver disease. A study of 200 cases. Gastroenterology 83 (1982) 786-796
50. Wanless I.R. Vascular disorders. In: Burt A.D., Portmann B.C., and Ferrell L.D. (Eds). MacSween's Pathology of the Liver. (ed 5) (2006), Churchill Livingstone, Edinburgh 613-648
51. Colombat M., Charlotte F., Ratziu V., et al. Portal lymphocytic infiltrate in alcoholic liver disease. Hum Pathol 33 (2002) 1170-1174
52. Schwimmer J.B., Behling C., Newbury R., et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology 42 (2005) 641-649
53. Takase S., Takada N., Enomoto N., et al. Different types of chronic hepatitis in alcoholic patients: does chronic hepatitis induced by alcohol exist?. Hepatology 13 (1991) 876-881
54. Morgan M.Y., Sherlock S., and Scheuer P.J. Portal fibrosis in the livers of alcoholic patients. Gut 19 (1978) 1015-1021
55. Michalak S., Rousselet M.C., Bedossa P., et al. Respective roles of porto-septal and centrilobular fibrosis in alcoholic liver disease. J Pathol 201 (2003) 55-62
56. Afroudakis A., and Kaplowitz N. Liver histopathology in chronic common bile duct stenosis due to chronic alcoholic pancreatitis. Hepatology 1 (1981) 65-72
57. Ray M.B., Mendenhall C.L., French S.W., et al., The Veterans Administration Cooperative Study Group. Bile duct changes in alcoholic liver disease. Liver 13 (1993) 36-45
58. Karakucuk I., Dilly S.A., and Maxwell J.D. Portal tract macrophages are increased in alcoholic liver disease. Histopathology 14 (1989) 245-253
59. Roskams T., and Desmet V. Ductular reaction and its diagnostic significance. Semin Diag Pathol 15 (1998) 259-269
60. Roskams T., Yang S.Q., Koteish A., et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163 (2003) 1301-1311
61. Jakobovits A.W., Morgan M.Y., and Sherlock S. Hepatic siderosis in alcoholics. Dig Dis Sci 24 (1979) 305-310
62. Kohgo Y., Ohtake T., Ikuta K., et al. Iron accumulation in alcoholic liver disease. Alcohol Clin Exp Res 29 suppl (2005) 189S-193S
63. Tavill A.S., and Qadri A.M. Alcohol and iron. Semin Liver Dis 24 (2004) 317-325
64. MacDonald R.A. Wine as source of iron in haemochromatosis. Nature 199 (1963) 922
65. Pascoe A., Kerlin P., and Jones D. Spur cell anemia explains the iron overload in advanced cirrhosis (C282Y negative). Hepatology 32 (2000) 159
66. Raynard B., Balian A., Fallik D., et al. Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 35 (2002) 635-638
67. Eng S.C., Taylor S.L., Reyes V., et al. Hepatic iron overload in alcoholic end-stage liver disease is associated with iron deposition in other organs in the absence of HFE-1 hemochromatosis. Liver Int 25 (2005) 513-517
68. Cortes J.M., Oliva H., Paradinas F.J., et al. The pathology of the liver in porphyria cutanea tarda. Histopathology 4 (1980) 471-485
69. Gerber M.A., and Thung S.N. Hepatic oncocytes. Incidence, staining characteristics, and ultrastructural features. Am J Clin Pathol 75 (1981) 498-503
70. Levitsky J., and Mailliard M.E. Diagnosis and therapy of alcoholic liver disease. Semin Liver Dis 24 (2004) 233-247
71. Watt K.D.S., and McCashland T.M. Transplantation in the alcoholic patient. Semin Liv Dis 24 (2004) 249-255
72. Fauerholdt L., Schlichting P., Christensen E., et al. Conversion of micronodular cirrhosis into macronodular cirrhosis. Hepatology 3 (1983) 928-931
73. Naveau S., Giraud V., Borotto E., et al. Excess weight risk factor for alcoholic liver disease. Hepatology 25 (1997) 108-111
74. Diehl A.M. Obesity and alcoholic liver disease. Alcohol 34 (2004) 81-87
75. Powell E.E., Ali A., Clouston A.D., et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129 (2005) 1937-1943
76. Hayashi P.H., Harrison S.A., Torgerson S., et al. Cognitive lifetime drinking history in nonalcoholic fatty liver disease: some cases may be alcohol related. Am J Gastroenterol 99 (2004) 76-81
77. Gomes de Sa Ribeiro M.F., da Costa Gayotto L.C., de Alencar Fischer Chamone D., et al. Alcoholic intake predisposes to more interface hepatitis in chronic hepatitis C. Ann Hepatol 4 (2005) 176-183
78. Tamai T., Seki T., Shiro T., et al. Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopathological study. Alcohol Clin Exp Res 24 suppl (2000) 106S-111S
79. Tanaka T., Yabusako T., Yamashita T., et al. Contribution of hepatitis C virus to the progression of alcoholic liver disease. Alcohol Clin Exp Res 24 suppl (2000) 112S-116S
80. Safdar K., and Schiff E.R. Alcohol and hepatitis C. Semin Liver Dis 24 (2004) 305-315
81. Fletcher L.M., and Powell L.W. Hemochromatosis and alcoholic liver disease. Alcohol 30 (2003) 131-136
82. Morita Y., Ueno T., Sasaki N., et al. Comparison of liver histology between patients with non-alcoholic steatohepatitis and patients with alcoholic steatohepatitis in Japan. Alcohol Clin Exp Res 29 (2005) 277S-281S
83. Dunn W., Jamil L.H., Brown L.S., et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 41 (2005) 353-358
84. Forrest E.H., Evans C.D., Stewart S., et al. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 54 (2005) 1174-1179
85. Thabut D., Naveau S., Charlotte F., et al. The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease. J Hepatol 44 (2006) 1175-1185
86. Chedid A., Mendenhall C.L., Gartside P., et al., VA Cooperative Study Group. Prognostic factors in alcoholic liver disease. Am J Gastroenterol 86 (1991) 210-216
87. Talley N.J., Roth A., Woods J., et al. Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol 10 (1988) 647-650
88. Nissenbaum M., Chedid A., Mendenhall C., et al. Prognostic significance of cholestatic alcoholic hepatitis. Dig Dis Sci 35 (1990) 891-896
89. Matteoni C.A., Younossi Z.M., Gramlich T., et al. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116 (1999) 1413-1419
90. Desmet V.J., and Roskams T. Cirrhosis reversal: a duel between dogma and myth. J Hepatol 40 (2004) 860-867
91. Kleiner D.E., Brunt E.M., Van Natta M., et al. Design and validation of a histological scoring system for non-alcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
92. Brunt E.M., Janney C.G., Di Bisceglie A.M., et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
93. Verill C.L., Markham H., and Sheron N. Correlation of histological features on liver biopsy in patients with alcohol-induced cirrhosis. J Pathol 210 suppl (2006) 21A